Breast – Invasive breast cancer of no special type (NST) with strong Bcl-2 positivity of all tumor cells_
Breast – Invasive breast cancer of no special type (NST) with weak Bcl-2 staining of all tumor cells_
Breast – Invasive lobular breast cancer with strong Bcl-2 immunostaining of all tumor cells_
Colon – Bcl-2 negative colorectal adenocarcinoma_
Colon – Colorectal adenocarcinoma with faint Bcl-2 staining of _10_ of tumor cells_
Kidney – Bcl-2 negative oncocytoma_
Kidney – Clear cell renal cell carcinoma with faint Bcl-2 immunostaining of a subset of tumor cells_
Kidney – Clear cell renal cell carcinoma with faint Bcl-2 staining of a fraction of tumor cells. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Kidney – Papillary renal cell carcinoma with strong Bcl-2 immunostaining of all tumor cells_
Lung – Bcl-2 negative adenocarcinoma. Strong Bcl-2 positivity of many tumor infiltrating lymphocytes_
Lung – Bcl-2 negative malignant mesothelioma (epitheloid)_
Lung – Bcl-2 negative malignant mesothelioma (epitheloid). Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Lung – Squamous cell carcinoma with weak Bcl-2 staining of most tumor cells_
Oral cavity – Bcl-2 negative squamous cell carcinoma. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Ovary – Endometroid carcinoma with moderate to strong Bcl-2 staining of tumor cells_
Ovary – Endometroid carcinoma with strong Bcl-2 immunostaining of tumor cells_
Ovary – Serous high-grade carcinoma with weak to moderate Bcl-2 positivity of most tumor cells_
Pharynx – Bcl-2 negative squamous cell carcinoma. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes (2)
Pharynx – Bcl-2 negative squamous cell carcinoma. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Prostate – Adenocarcinoma (Gleason 3+4=7) with moderate Bcl-2 staining in _50_ of tumor cells_
Prostate – Bcl-2 negative adenocarcinoma (Gleason 3+3=6). Tumor adjacent normal glands show a weak to moderate staining (most prominent in basal cells)_
Testis – Bcl-2 negative seminoma. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Thyroid – Papillary cancer with weak Bcl-2 staining of all tumor cells_
Thyroid – Papillary cancer with weak to moderate Bcl-2 staining of most tumor cells_
Urinary bladder – Bcl-2 negative muscle-invasive urothelial carcinoma_
Urinary bladder – Bcl-2 negative muscle-invasive urothelial carcinoma. Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
Urinary bladder – Bcl-2 negative non-invasive papillary urothelial carcinoma (pTa). Distinct Bcl-2 positivity of many tumor infiltrating lymphocytes_
